Hyperfine

Hyperfine, Inc. is a medical device development company engaged in the development of, MRI solutions and non-invasive neural monitoring technology. The company was founded by Jonathan M. Rothberg on February 25, 2014 and is headquartered in Guilford, CT.

Earnings data Q1 2024

HYPR achieves record revenue in Q1 2023, faces cost management challenges

HYPR's Q1 2023 performance reflects strong revenue growth and a focus on strategic areas of innovation and expansion. However, the company faces challenges in managing costs and deal closure timelines. Opportunities lie in growing market demand and efforts to improve operational efficiency.

HYPR reports record Q2 revenue but faces significant net loss

HYPR achieved record revenue in Q2 2023 but also reported a significant net loss, emphasizing the need for cost management. The company's focus on innovation, clinical evidence, and commercial expansion demonstrates a commitment to growth. With a strong leadership team and opportunities for expansion, HYPR is poised for future success despite financial challenges.

HYPR reports robust Q3 performance, eyes medical imaging innovation

HYPR's Q3 2023 earnings call highlighted strong financial performance, strategic collaborations, and a focus on innovation in medical imaging technology. The company's achievements in revenue growth, gross margin improvement, and FDA clearance for software updates position it well for future success. Challenges include maintaining market leadership and executing planned studies effectively, while opportunities lie in further innovation and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M. Rothberg and Ronald Walsworth on February 25, 2014 and is headquartered in Guilford, CT.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. at ISMRM with 17 abstracts assessing the potential of using Swoop® System images across multiple care settings and clinical conditions.

Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions

GUILFORD, Conn.--(BUSINESS WIRE)--Leading institutions enroll first Alzheimer's patients receiving amyloid-targeting therapy in CARE PMR study.

Leading Institutions Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study

Hyperfine, Inc. (HYPR) Q4 2023 Earnings Call Transcript

Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.19 per share a year ago.

Hyperfine, Inc. (HYPR) Reports Q4 Loss, Lags Revenue Estimates

GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2023 financial results and provided a business update.

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. collaborates with King's College London to demonstrate the Swoop® system and UNITY Project to The Princess Royal.

Hyperfine, Inc. Collaborates with King's College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to announce fourth quarter and full year 2023 financial results on March 21, 2024.

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the Oppenheimer 34th Annual Healthcare Conference.

Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference

GUILFORD, Conn. & ORLANDO, Fla.--(BUSINESS WIRE)--Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes.

Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. presents data at 2024 International Stroke Conference and provides an update on enrollment in ACTION PMR stroke observational study.

Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. launches AI-powered brain imaging software for enhanced image quality and ease of use.

Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces presentations on clinical advancements at RSNA 2023.

Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the Piper Sandler 35th annual healthcare conference.

Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference

Hyperfine, Inc. (NASDAQ:HYPR ) Q3 2023 Earnings Call November 9, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Neil Chatterji - B. Riley Operator Good afternoon, and welcome to Hyperfine's Third Quarter 2023 Earnings Conference Call.

Hyperfine, Inc. (HYPR) Q3 2023 Earnings Call Transcript

GUILFORD, Conn., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world's first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced third quarter 2023 financial results and provided a business update.

Hyperfine, Inc. Reports Third Quarter 2023 Financial Results

GUILFORD, Conn.--(BUSINESS WIRE)--Observational study finds that Hyperfine, Inc. portable MR brain imaging system assists clinicians in early detection of ABI in ECMO patients.

Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to announce third quarter financial results on November 9, 2023.

Hyperfine, Inc. to Announce Third Quarter Financial Results on November 9, 2023

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces promotions of two key clinical affairs executives.

Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs Executives

Hyperfine's (HYPR) updated Swoop software is expected to make brain imaging more accessible and clinically relevant.

Hyperfine (HYPR) Progresses in MRI Space With Latest FDA Nod

ING Groep NV

Successful investing is about anticipating others' anticipation. The value of a stock is based on what people think it's worth. Selling shares of Hyperfine may be a great opportunity for buyers.

Hyperfine: Swoop-Ing In On The Low-Field MRI Opportunity

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. receives FDA clearance for updated AI-powered software with improved image quality for all Swoop® system sequences.

Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences

Hyperfine, Inc. (HYPR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Down -21.28% in 4 Weeks, Here's Why Hyperfine, Inc. (HYPR) Looks Ripe for a Turnaround

Hyperfine, Inc. (HYPR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Down -15.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Hyperfine, Inc. (HYPR)

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable magnetic resonance brain imaging system, today announced plans to participate at the upcoming Gilmartin Group Emerging Growth Showcase, taking place virtually. Members of management are scheduled to present on Thursday, September 21, 2023, at 1:00 pm ET. Interested parties can register and access a live webcast of the.

Hyperfine, Inc. to Present at Gilmartin Group Emerging Growth Showcase

The heavy selling pressure might have exhausted for Hyperfine, Inc. (HYPR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

News for Hyperfine Stock (HYPR)